Learn More
Medchemexpress LLC Rbn-3143 | 2360853-16-1 | 99.3% | 449.54 g/mol | C22H28FN3O4S | 10 MG

Supplier: Medchemexpress LLC HY15020710MG
RBN-3143 is a small-molecule, NAD+-competitive catalytic inhibitor of PARP14 with reported nanomolar potency (IC50 ≈ 4 nM). It inhibits PARP14-mediated ADP-ribosylation, stabilizes PARP14 in cell lines, and is provided for research use to support studies of PARP14 biology and inflammatory disease models.
- NAD+-competitive catalytic inhibitor of PARP14.
- Reported IC50 ≈ 4 nM against PARP14.
- Inhibits PARP14-mediated ADP-ribosylation in cell assays.
- Stabilizes PARP14 protein in cell lines.
- High reported chemical purity (~99.3%).
- Available in multiple research pack sizes for laboratory studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.